EE13 Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Portugal
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.267
https://www.valueinhealthjournal.com/article/S1098-3015(22)02471-8/fulltext
Title :
EE13 Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Portugal
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02471-8&doi=10.1016/j.jval.2022.09.267
First page :
Section Title :
Open access? :
No
Section Order :
12069